Skip to main content
. 2023 Mar 6;10(1):e001508. doi: 10.1136/bmjresp-2022-001508

Figure 4.

Figure 4

Clinical factors and outcomes of patients by inhaler prescription. AO, airflow obstruction; BDR, bronchodilator response; Br, bronchiectasis; COPD, chronic obstructive pulmonary disease; +ICS, plus inhaled corticosteroids; MI, mixed impairment; PHC, primary healthcare; RI, restrictive impairment; LABA, long-acting β-agonists; LAMA, long-acting muscarinic antagonists; LRTI, lower respiratory tract infection; SABA, short-acting bronchodilators; SAMA, short-acting muscarinic antagonists.